Diabetes - sick day management

In this episdoes Ryan Paul discusses sick day management in the patient with diabetes.

Topics

Intro
Play now
Should all patients with diabetes have a sick day plan?
Play now
What's a sick day plan look like?
Play now
What sort of monitoring should we be telling our unwell diabetic patients to do
Play now
At what point should we consider admission to hospital?
Play now
Different classes of medications - What medications may need to be altered or stopped?
Play now
Sulphonylureas
Play now
Metformin
Play now
Sglt2 inhibitors
Play now
Diabetic ketoacidosis
Play now
Differentiating one from the other
Play now
What a patient should expect on admission to hospital
Play now
Restarting medications
Play now
Type 2 diabetic patients and COVID
Play now
Dexamethasone
Play now
Managing dexamethasone patients in the community
Play now
Take-home messages
Play now

Take home messages

All patients with diabetes should have a sick day management plan
Regular monitoring of glucose levels is vital in the unwell patient with diabetes
SGLT2i need to be stopped when unwell to prevent diabetic ketoacidosis
Other glucose lowering agents may also need to be stopped depending on the illness
Proactive escalation of therapy is often required to prevent significant steroid-induced hyperglycaemia risk

Resources

Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use New Zealand Society for the study of Diabetes
Sick day management in patients with diabetes New Zealand Society for the study of Diabetes
SGLT2 inhibitors New Zealand Society for the study of Diabetes
Sick day plan for type 1 diabetes Health Navigator
Sick day plan for type 2 diabetes Health Navigator

Patient Resources

Presenter

Ryan Paul

Endocrinologist

Ryan is a Diabetologist at the Waikato District Health Board and a Senior Lecturer at the University of Waikato. Particular research interests include the use of emerging technologies in type 1 diabetes, the management of diabetes in youth and young adults, reducing inequities in diabetes care in Māori and rural populations, and improving models of diabetes care. Ryan has just stepped down as the President of the New Zealand Society of Endocrinology (NZSE) and is an Executive Member of the New Zealand Society for the Study of Diabetes (NZSSD). Ryan is a Clinical Associate of the Maurice Wilkins Centre and was awarded the New Zealand Clinical Educator of the Year by the New Zealand Medical Council in 2019.